About

CORPORATE PROFILE

GI Dynamics, Inc. (ASX: GID) is the developer of EndoBarrier®, the first endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and/or obesity... Read more...
ASX : GID.AX (CHESS Depository Interests)
A$0.06 - 0.01
Stock chart for: GID.AX.  Currently trading at A$0.06 with a 52 week high of A$0.09 and a 52 week low of A$0.02.
Feb 24, 2017 3:55 p.m.
AUS EST
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
RECENT NEWSView All
Feb-01-2017

EndoBarrier® Receives German NUB Reimbursement Status 1 for Type 2 Diabetes and Obesity Therapy

BOSTON & SYDNEY--(BUSINESS WIRE)--Feb. 1, 2017-- GI Dynamics, Inc., (ASX:GID), a m

Read More

Jan-11-2017

GI Dynamics, Inc. Provides 2017 Business Outlook and 2016 Review

BOSTON & SYDNEY--(BUSINESS WIRE)--Jan. 11, 2017-- GI Dynamics, Inc., (ASX:GID), a

Read More

INVESTOR CONTACT

Main:
  investor@gidynamics.com
+1 781-357-3250 (U.S.)

SHARE REGISTRY

Link Market Services Limited
General Shareholder Enquiries:
Phone: 1300 554 474 (toll free) or +61 2 8280 7111
  registrars@linkmarketservices.com.au
Fax: +61 2 9287 0303
Online investor log-in
  Locked Bag A14
    Sydney South NSW 1235
    Australia

Quote is a for a CHESS Depositary Interests (CDI)
1 share of common stock = 50 CDIs